rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-10-16
|
pubmed:abstractText |
Understanding the effect of oral contraceptives on risk of breast cancer in BRCA1 or BRCA2 mutation carriers is important because oral contraceptive use is a common, modifiable practice.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1055-9965
|
pubmed:author |
pubmed-author:AndrewsLesleyL,
pubmed-author:AndrulisIrene LIL,
pubmed-author:ApicellaCarmelC,
pubmed-author:BaneAnitaA,
pubmed-author:BuysSaundra SSS,
pubmed-author:DalyMary MMM,
pubmed-author:FelbergAnnaA,
pubmed-author:GilesGraham GGG,
pubmed-author:GodwinAndrew KAK,
pubmed-author:HaileRobert WRW,
pubmed-author:HopperJohn LJL,
pubmed-author:JenkinsMark AMA,
pubmed-author:JohnEsther MEM,
pubmed-author:KnightJulia AJA,
pubmed-author:LevineA JoanAJ,
pubmed-author:McCredieMargaret R EMR,
pubmed-author:McGuireValerieV,
pubmed-author:MilneRoger LRL,
pubmed-author:MironAlexanderA,
pubmed-author:Ontario Cancer Genetics Network Investigators,
pubmed-author:PikeMalcolm CMC,
pubmed-author:SenieRuby TRT,
pubmed-author:SoutheyMelissaM,
pubmed-author:TesorieroAndreaA,
pubmed-author:ThomasDuncan CDC,
pubmed-author:TuckerKatherineK,
pubmed-author:WhittemoreAlice SAS,
pubmed-author:kConFab Investigators
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1863-70
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17021353-Adult,
pubmed-meshheading:17021353-Australia,
pubmed-meshheading:17021353-Breast Neoplasms,
pubmed-meshheading:17021353-Canada,
pubmed-meshheading:17021353-Carcinoma, Ductal, Breast,
pubmed-meshheading:17021353-Carcinoma in Situ,
pubmed-meshheading:17021353-Case-Control Studies,
pubmed-meshheading:17021353-Contraceptives, Oral,
pubmed-meshheading:17021353-Female,
pubmed-meshheading:17021353-Genes, BRCA1,
pubmed-meshheading:17021353-Genes, BRCA2,
pubmed-meshheading:17021353-Genetic Predisposition to Disease,
pubmed-meshheading:17021353-Heterozygote,
pubmed-meshheading:17021353-Humans,
pubmed-meshheading:17021353-Logistic Models,
pubmed-meshheading:17021353-Middle Aged,
pubmed-meshheading:17021353-Mutation,
pubmed-meshheading:17021353-Questionnaires,
pubmed-meshheading:17021353-Receptors, Estrogen,
pubmed-meshheading:17021353-Receptors, Progesterone,
pubmed-meshheading:17021353-Risk Factors,
pubmed-meshheading:17021353-Time Factors,
pubmed-meshheading:17021353-United States
|
pubmed:year |
2006
|
pubmed:articleTitle |
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
|
pubmed:affiliation |
Department of Preventive Medicine, University of Southern California-Keck School of Medicine, 1441 Eastlake Avenue, MS 9175, Los Angeles, CA 90089-9175, USA. haile@usc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|